← Back to Search

Low-Field MRI for Pediatric ECMO Patients

N/A

Waitlist Available

Led By Jessica Wallisch, MD

Research Sponsored by Children's Mercy Hospital Kansas City

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 0-17 years

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre intervention during patient prep, and during intervention, and immediately intervention.

Awards & highlights

No Placebo-Only Group

Summary

This trial tests the safety and effectiveness of a low-field MRI for ECMO patients, comparing it to traditional imaging techniques. Data will be collected to help optimize the device performance.

Who is the study for?

This trial is for children and teens (ages 0-17) in intensive care units who are on a life-support technique called ECMO. It's not for those who are pregnant, have devices like pacemakers or metal implants, tattoos with metal ink near the head or neck, suspected metal in their eye, or any MRI-incompatible surgical hardware.

What is being tested?

The study tests the safety and feasibility of using a new low-field MRI machine right at the bedside of young patients on ECMO. The goal is to get clear images of the brain without moving these critically ill patients to standard imaging facilities.

What are the potential side effects?

Since this trial focuses on testing an imaging device rather than a medication, traditional side effects aren't expected. However, there may be risks associated with using an MRI machine around other medical equipment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 17 years old or younger.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre intervention during patient prep, during intervention, and immediately after intervention.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre intervention during patient prep, during intervention, and immediately after intervention.

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre intervention during patient prep, during intervention, and immediately after intervention. for reporting.